The G-231A Polymorphism in the Endothelin-A Receptor Gene Is Associated With Lower Aortic Pressure in Patients With Dilated Cardiomyopathy

American Journal of Hypertension

Volumn 20, Issue 1, 2007, Pages 32-37

  Telgmann, Ralph ^a   Harb, Bassam A ^c   Ozcelik, Cemil ^c   Perrot, Andreas ^c   Schönfelder, Jacqueline ^c   Nonnenmacher, Andreas ^c   Brand, Marcus ^b   Schmidt Petersen, Klaus ^a,b   Dietz, Rainer ^c   Kreutz, Reinhold ^c   Osterziel, Karl Josef ^c   Paul, Martin ^c   Brand Herrmann, Stefan Martin ^a,c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

aortic pressure; Dilated cardiomyopathy; endothelin A receptor; genetics; polymorphism

Indexed keywords

AMIODARONE; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN A RECEPTOR; HYDROCHLOROTHIAZIDE; METOPROLOL; NITRATE; RAMIPRIL;

ADULT; AGE DISTRIBUTION; ALLELE; AORTA PRESSURE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; ENDOTHELIN A RECEPTOR GENE; EXON; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RNA TRANSLATION; SEX ROLE; STATISTICAL SIGNIFICANCE;

AGED; AORTA; BASE SEQUENCE; BLOOD PRESSURE; CARDIOMYOPATHY, DILATED; CORONARY ANGIOGRAPHY; EXONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ENDOTHELIN A;

EID: 33845790721     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.06.016     Document Type: Article

References (27)

1. Michels V.V., Moll P.P., Miller F.A., Tajik A.J., Chu J.S., Driscoll D.J., Burnett J.C., Rodeheffer R.J., Chesebro J.H., and Tazelaar H.D. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 326 (1992) 77-82
2. Keeling P.J., Gang Y., Smith G., Seo H., Bent S.E., Murday V., Caforio A.L., and McKenna W.J. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J 73 (1995) 417-421
3. Grünig E., Tasman J.A., Kücherer H., Franz W., Kübler W., and Katus H.A. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 31 (1998) 186-194
4. Pieske B., Beyermann B., Breu V., Loffler B.M., Schlotthauer K., Maier L.S., Schmidt-Schweda S., Just H., and Hasenfuss G. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 99 (1999) 1802-1809
5. Zolk O., Quattek J., Sitzler G., Schrader T., Nickenig G., Schnabel P., Shimada K., Takahashi M., and Bohm M. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation 99 (1999) 2118-2123
6. Ponicke K., Vogelsang M., Heinroth M., Becker K., Zolk O., Bohm M., Zerkowski H.R., and Brodde O.E. Endothelin receptor in the failing and nonfailing human heart. Circulation 97 (1998) 744-751
7. Rothermund L., and Paul M. The role of endothelin in hypertension. Curr Opin Nephrol Hypertens 4 (1998) 451-456
8. Berger R., Stanek B., Hulsmann M., Frey B., Heher S., Pacher R., and Neunteufl T. Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure. Circulation 103 (2001) 981-986
9. Torre-Amione G., Young J.B., Durand J., Bozkurt B., Mann D.L., Kobrin I., and Pratt C.M. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Circulation 103 (2001) 973-980
10. Herrmann S.M., Schmidt-Petersen K., Pfeifer J., Perrot A., Bit-Avragim N., Eichhorn C., Dietz R., Kreutz R., Paul M., and Osterziel K.J. A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy. Eur Heart J 22 (2001) 1948-1953
11. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gurgesell H., Reichek N., Sahn D., Schnittger I., Silverman N.H., and Tajik A.J. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiog 2 (1989) 358-367
12. Sahn D.J., DeMaria A., Kisslo J., and Weyman. A Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
13. Sandler H., and Dodge H.T. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 75 (1968) 325-334
14. Vasan R.S., Larson M.G., Levy D., Evans J.C., and Benjamin E.J. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart study: formulation of a height- and sex-specific classification and its prospective validation. Circulation 96 (1997) 1863-1873
15. Miller G.A.H., and Denison D. The measurement of pressure and of oxygenation. In: Miller, and Graham (Eds). Invasive Investigation of the Heart (1989), Blackwell Scientific Publications, Oxford, London 81-99
16. Hosoda K., Nakao K., Tamura N., Arai H., Ogawa Y., Suga S., Nakanishi S., and Imura H. Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor. J Biol Chem 267 (1992) 18797-18804
17. Herrmann S.M., Ricard S., Nicaud V., Mallet C., Evans A., Ruidavets J.B., Arveiler D., Luc G., and Cambien F. The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet 7 (1998) 1277-1284
18. Nicaud V., Poirier O., Behague I., Herrmann S.M., Mallet C., Troesch A., Bouyer J., Evans A., Luc G., Ruidavets J.B., Arveiler D., Bingham A., Tiret L., and Cambien F. Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction the Etude Cas-Temoins sur l'Infarctus du Myocarde (ECTIM) study. Am J Hypertens 12 (1999) 304-310
19. Rouleau J.L., Roecker E.B., Tendera M., Mohacsi P., Krum H., Katus H.A., Fowler M.B., Coats A.J., Castaigne A., Scherhag A., Holcslaw T.L., Packer M., and Carvedilol Prospective Randomized Cumulative Survival Study Group. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. J Am Coll Cardiol 43 (2004) 1423-1429
20. Wenzel R.R., Siffert W., Bruck H., Philipp T., and Schafers R.F. Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation. Pharmacogenetics 12 (2002) 489-495
21. Mitchell A., Luckebergfeld B., Buhrmann S., Rushentsova U., Nurnberger J., Siffert W., Schafers R.F., Philipp T., and Wenzel R.R. Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism. Clin Pharmacol Ther 76 (2004) 396-408
22. Mitchell A., Rushentsova U., Siffert W., Philipp T., and Wenzel R.R. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism. Clin Pharmacol Ther 79 (2006) 274-281
23. Yamashita J., Yoshimasa T., Arai H., Hiraoka J., Takaya K., Miyamoto Y., Ogawa Y., Itoh H., and Nakao K. Identification of cis-elements of the human endothelin-A receptor gene and inhibition of the gene expression by the decoy strategy. J Biol Chem 273 (1998) 15993-15999
24. Veniant M., Clozel J.P., Hess P., and Clozel M. Endothelin plays a role in the maintenance of blood pressure in normotensive guinea pigs. Life Sci 55 (1994) 445-454
25. Munter K., Ehmke H., and Kirchengast M. Maintenance of blood pressure in normotensive dogs by endothelin. Am J Physiol 276 (1999) H1022-H1027
26. Kalra P.R., Moon J.C.C., and Coats A.J.S. Do results on the ENABLE (Endothelin Antagonism Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?. Int J Cardiol 85 (2002) 195-197
27. Coletta A.P., Louis A.A., Clark A.L., Nikitin N., and Cleland J.G. Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II. Eur J Heart Fail 4 (2002) 661-666